Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Adolescents treated for obesity with GLP-1 drugs had lower risk of suicidal thoughts, study finds
A review of the medical records of thousands of adolescents treated for obesity found that kids who received the GLP-1 medications semaglutide or liraglutide were less likely to have suicidal thoughts or attempts than those treated with behavioral interventions.
Study: GLP-1 weight-loss drugs might lower, not increase, teen suicide risk
In a new study, obese kids who used GLP-1 weight-loss drugs had a 33% decline in their risk for thoughts of suicide and suicide attempts compared to adolescents who didn't.
GLP-1 Stocks Aren't the Only Way to Benefit From the Weight Loss Drugs Boom
However, GLP-1-based therapies aren't going to be the only option in the weight loss medicines market forever. Some companies are pursuing other approaches that could be even more effective or complementary to the existing interventions.
GLP-1 drugs like Ozempic may protect brain health, several studies show
A review of the recent evidence suggests that GLP-1 drugs, such as semaglutide, could protect brain health and cognitive function by reducing inflammation.
3 More Benefits GLP-1 Drugs Like Ozempic May Provide in Addition to Weight Loss
New research suggests GLP-1 medications like Ozempic may help reduce several health risks in addition to treating type 2 diabetes and obesity.
Teens With Obesity Less Likely to Be Suicidal on Weight Loss Drugs: Study
Weight loss drugs like Ozempic were associated with a lower risk of suicidal thoughts in teens with obesity, a new study found.
Anti-obesity drugs tied to lower risk of suicidal thoughts or attempts among young people - study
Researchers said the drugs don’t appear to raise the risk of suicidal thoughts or actions for young people but also urged caution in interpreting the results.View on euronews
Risk for Suicidal Ideation, Attempts Down With GLP1-RA Treatment in Teens With Obesity
For adolescents with obesity, glucagon-like peptide 1 receptor agonist (GLP1-RA) treatment is associated with a reduced risk for suicidal ideation or attempts, according to a study published online Oct.
Study says Ozempic may reduce the risk of suicide in obese teens
The iconic movies everyone should watch at least once before they die, according to critics ‘Stunning’ hidden tomb found at Petra site featured in ‘Indiana Jones’ Steelers' Ben Roethlisberger Believes
FierceBiotech
17h
Chinese insulin maker says its GLP-1 beat Ozempic at lowering blood sugar, body weight in phase 2
Chinese insulin maker Gan & Lee Pharmaceuticals is wading into the obesity world with an injectable GLP-1 agonist that beat Novo Nordisk's Ozempic (semaglutide) at lowering glycated hemoglobin (HbA1c) ...
7d
on MSN
With Its GLP-1 Drugs No Longer in a Shortage, Is Now the Time to Buy Eli Lilly Stock?
While artificial intelligence (AI) has been one of the hottest investing trends, GLP-1 weight loss drugs are a close second.
News Medical on MSN
1d
Dietitians boost GLP-1 therapy success with personalized care and side effect management
Researchers reveal the importance of personalized communication and side effect management in improving outcomes for patients ...
Managed Healthcare Executive
3d
Are PBMs Putting GLP-1 Drugs on Their Formularies?
PBMs are putting weight loss drugs, including Wegovy and Zepbound, on their national formularies, but coverage by plans is ...
1d
LifeVantage Introduces the MindBody GLP-1 System™ Transforming Weight Management into a Sustainable Lifestyle
Met With High Demand, the Dual-Product System is Clinically Shown to Increase GLP-1 by 140% on average to Balance Hunger ...
Business Wire
12d
Digbi Health to Present Groundbreaking Study on Gut Microbiome's Role in Enhancing Endogenous GLP-1 Production at 2024 Obesity Society Conference
Digbi Health, a leader in Precision Biology and personalized healthcare, has been invited to present a landmark study at the ...
1d
on MSN
FDA Reversal on Knockoff GLP-1 Drugs Brings Confusion, and Few Answers
A rapid-fire reversal from the Food and Drug Administration has injected even more uncertainty into what was already a wild ...
5d
The Crackdown on Compounded GLP-1 Meds Has Begun
Now that the Mounjaro and Zepbound shortage is over, Eli Lilly is going after the cottage industry selling “compounded” ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
Food and Drug Administration
Medicare
Wegovy
Zepbound
Novo Nordisk
Feedback